Medical Optics News

RSS

Researchers Transform Waste Sulfur into Cheap, Lightweight, Plastic Lenses for Infrared Devices

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans.

18 Apr 2014

Endofotonics’ IMDX System Enables Almost Instantaneous Cancer Diagnosis during Endoscopy

Mrs Lim was advised to go for a gastroscope due to persistent gastric discomfort. Some abnormal looking lesions were detected during the gastroscope examination. A thin probe was inserted through the gastroscope into Mrs Lim's gastrointestinal tract, molecular information of the abnormal tissues was obtained, a clinical diagnosis was made in real time and the pre-cancerous lesions were removed at the same setting.

17 Apr 2014

$PediaVision’s Portable, Lightweight, Wi-Fi-Enabled, Binocular Autorefractor Simplifies Patient Care$

PediaVision’s Portable, Lightweight, Wi-Fi-Enabled, Binocular Autorefractor Simplifies Patient Care

Spot, the handheld binocular autorefractor from PediaVision, is garnering praise from ophthalmology and optometry practices as a sound investment that has enabled them to simplify patient care in multiple ways. Among the device's fans are the Hunkeler Eye Institute, P.A. in Overland Park, Kan., Arizona Vision in Phoenix, Ariz., Genoa Family Eye Care in Ohio and Southridge Optical in Greendale, Wis.

11 Apr 2014

TecMed Sets New Standard in Blood Glucose Measurement Technologies with Optical Measurement IP

Today TecMed, Inc. announced that its optical measurement IP has set a new standard in blood glucose measurement technologies. TecMed's IP is reported to have the greatest precision in the measurement of blood glucose, and other chiral molecules, compared to other technologies currently commercially available.

9 Apr 2014

FDA Approves RPCI’s Phase II Clinical Trial for Delivering I-PDT to Recurrent Tumors

Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.

3 Apr 2014

Guided Therapeutics Seeks Meeting with FDA for LuViva Advanced Cervical Scan Approval

Guided Therapeutics, Inc. today announced that the company has submitted a letter requesting a face-to-face meeting with the U.S. Food and Drug Administration (FDA) in the next 60 to 90 days. This letter is in response to the September 6, 2013 letter that the company received from the FDA. Additionally, the FDA has granted the company its requested 180 day extension on the PMA filing to allow time for the meeting to occur.

29 Mar 2014

Optiguide DCYL700 Fiber Optic Diffuser Series Receives FDA Premarket Supplemental Approval

Concordia Healthcare Corp. ("Concordia") announced today that its subsidiary Pinnacle Biologics, Inc. ("Pinnacle"), a biopharmaceutical research and development company specializing in rare diseases, was granted U.S. Food and Drug Administration (FDA) premarket supplemental approval (PMA) for its Optiguide® DCYL700 Fiber Optic Diffuser Series flexible fiber.

27 Mar 2014

OmniGuide Surgical Supplies Over 100,000 Flexible Fibers for Treatment of Debilitating Diseases

OmniGuide Surgical, a leading developer of advanced energy surgical products, today announced it has shipped more than 100,000 of its flexible fibers for the treatment of a range of debilitating diseases in areas such as Otolaryngology and Gynecology.

27 Mar 2014

Light Controls Biological Activity of Antibiotic

Scientists of the KIT and the University of Kiev have produced an antibiotic, whose biological activity can be controlled with light. Thanks to the robust diarylethene photoswitch, the antimicrobial effect of the peptide mimetic can be applied in a spatially and temporally specific manner.

24 Mar 2014

New Optical Device Permits Noninvasive, Continuous Monitoring of Cerebral Blood Flow

Using a University of Pennsylvania-designed device to noninvasively and continuously monitor cerebral blood flow (CBF) in acute stroke patients, researchers from Penn Medicine and the Department of Physics & Astronomy in Penn Arts and Sciences are now learning how head of bed (HOB) positioning affects blood flow reaching the brain.

24 Mar 2014

Featured Equipment